Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Some of the most common or potential side effects include: Nausea Constipation Vomiting Diarrhea Abdominal Pain Headache Indigestion Injection site reactions Dizziness Back pain Increased Lipase or Amylase Altered taste Nasopharyngitis (common cold) Passing Gas Bloating Belching Gastroenteritis Decreased appetite Fatigue Gastroesophageal reflux disease Low blood sugar (hypoglycemia) in those with type II diabetes Upset stomach These symptoms often subside as your body adjusts to the medications
Research Rationale Retatrutide addresses systemic energy homeostasis through incretin and glucagon receptor signalling MOTS-C targets cellular energy sensing via AMPK and mitochondrial regulation Triple agonism (GLP-1 + GIP + glucagon) provides broader receptor coverage than single or dual agonists, while MOTS-C adds a mitochondrial dimension not addressed by incretin-based compounds Retatrutide modulates insulin and glucagon secretion in glucose-dependent in vitro models MOTS-C enhances glucose uptake and fatty acid oxidation in cultured myocytes and hepatocytes Each peptide is individually vialled with independent batch COAs titrate each separately in your assay design Research Applications Commonly employed in metabolic disease research using beta-cell lines (MIN6, INS-1), primary hepatocyte cultures, and 3T3-L1 adipocyte differentiation models
For people with more subcutaneous tissue If you carry more body fat, particularly in the thighs, you have several advantages
To avoid digestive discomfort, its important to increase fiber intake slowly and drink plenty of water throughout the day
